DexCom Inc (DXCM)
74.46
-0.78
(-1.04%)
USD |
NASDAQ |
Nov 21, 16:00
74.60
+0.14
(+0.19%)
After-Hours: 20:00
DexCom Enterprise Value: 29.03B for Nov. 21, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 21, 2024 | 29.03B |
| November 20, 2024 | 29.34B |
| November 19, 2024 | 29.20B |
| November 18, 2024 | 29.74B |
| November 15, 2024 | 29.59B |
| November 14, 2024 | 29.12B |
| November 13, 2024 | 28.28B |
| November 12, 2024 | 28.98B |
| November 11, 2024 | 27.41B |
| November 08, 2024 | 27.27B |
| November 07, 2024 | 26.86B |
| November 06, 2024 | 26.75B |
| November 05, 2024 | 26.90B |
| November 04, 2024 | 27.17B |
| November 01, 2024 | 27.43B |
| October 31, 2024 | 27.48B |
| October 30, 2024 | 27.99B |
| October 29, 2024 | 28.16B |
| October 28, 2024 | 28.11B |
| October 25, 2024 | 28.63B |
| October 24, 2024 | 29.18B |
| October 23, 2024 | 28.26B |
| October 22, 2024 | 28.49B |
| October 21, 2024 | 28.31B |
| October 18, 2024 | 28.22B |
| Date | Value |
|---|---|
| October 17, 2024 | 27.11B |
| October 16, 2024 | 27.25B |
| October 15, 2024 | 26.16B |
| October 14, 2024 | 26.97B |
| October 11, 2024 | 26.98B |
| October 10, 2024 | 27.12B |
| October 09, 2024 | 27.14B |
| October 08, 2024 | 27.07B |
| October 07, 2024 | 26.75B |
| October 04, 2024 | 26.55B |
| October 03, 2024 | 25.60B |
| October 02, 2024 | 26.16B |
| October 01, 2024 | 25.73B |
| September 30, 2024 | 26.13B |
| September 27, 2024 | 26.28B |
| September 26, 2024 | 26.38B |
| September 25, 2024 | 26.06B |
| September 24, 2024 | 26.83B |
| September 23, 2024 | 27.25B |
| September 20, 2024 | 27.54B |
| September 19, 2024 | 28.14B |
| September 18, 2024 | 27.15B |
| September 17, 2024 | 26.94B |
| September 16, 2024 | 27.40B |
| September 13, 2024 | 27.17B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
17.04B
Minimum
Mar 18 2020
62.13B
Maximum
Nov 17 2021
38.92B
Average
39.26B
Median
Mar 09 2022
Enterprise Value Benchmarks
| Orthofix Medical Inc | 802.25M |
| Abbott Laboratories | 210.81B |
| Edwards Lifesciences Corp | 37.73B |
| Senseonics Holdings Inc | 170.58M |
| Insulet Corp | 18.87B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 134.60M |
| Revenue (Quarterly) | 994.20M |
| Total Expenses (Quarterly) | 842.20M |
| EPS Diluted (Quarterly) | 0.34 |
| Gross Profit Margin (Quarterly) | 59.73% |
| Profit Margin (Quarterly) | 13.54% |
| Earnings Yield | 2.24% |
| Operating Earnings Yield | 2.03% |
| Normalized Earnings Yield | 2.243 |